| Stage | CMCSA | % of rev | VSNT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $29.3B | 100.00% | $1.6B | 100.00% | CMCSA ×17.82 |
| Gross profit | $21.8B | 74.35% | $994M | 60.46% | CMCSA +13.9pp |
| Operating income | $5.3B | 18.16% | $367M | 22.32% | VSNT +4.2pp |
| Pre-tax income | $4.4B | 15.18% | $323M | 19.65% | VSNT +4.5pp |
| Net income | $3.4B | 11.48% | $211M | 12.83% | VSNT +1.4pp |
| Stage | CMCSA | VSNT | Gap · A − B |
|---|---|---|---|
| Revenue | $29.3B100.00% | $1.6B100.00% | CMCSA ×17.82 |
| Gross profit | 74.35%$21.8B | 60.46%$994M | CMCSA +13.9pp |
| Operating income | 18.16%$5.3B | 22.32%$367M | VSNT +4.2pp |
| Pre-tax income | 15.18%$4.4B | 19.65%$323M | VSNT +4.5pp |
| Net income |
| 11.48%$3.4B |
| 12.83%$211M |
| VSNT +1.4pp |
No shared counterparties.